Presence of intratumoral platelets is associated with tumor vessel structure and metastasis

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Li, Rong ^a   Ren, Meiping ^a   Chen, Ni ^a   Luo, Mao ^a   Deng, Xin ^a   Xia, Jiyi ^a   Yu, Guang ^a   Liu, Jinbo ^a   He, Bing ^a   Zhang, Xu ^a   Zhang, Zhuo ^a   Zhang, Xiao ^a   Ran, Bing ^a   Wu, Jianbo ^a,b  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Angiogenesis; Hypoxia; Metastasis; Platelets; Tumorigenesis

Indexed keywords

EVANS BLUE; GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PAI 1 PROTEIN; SCATTER FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; ANGIOGENIC FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BLOOD VESSEL PERMEABILITY; CANCER MORPHOLOGY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FEMALE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; METASTASIS; MICRODIALYSIS; MILES VASCULAR PERMEABILITY ASSAY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTOPENIA; TUMOR GROWTH; TUMOR MICROENVIRONMENT; WESTERN BLOTTING; ANIMAL; ANOXIA; BLOOD VESSEL; CAPILLARY PERMEABILITY; DISEASE MODEL; EXPERIMENTAL MELANOMA; LUNG TUMOR; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SECONDARY; TUMOR VOLUME;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANOXIA; BLOOD PLATELETS; BLOOD VESSELS; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTO-ONCOGENE PROTEINS C-MET; TRANSFORMING GROWTH FACTOR BETA1; TUMOR BURDEN;

EID: 84897557096     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-167     Document Type: Article

References (31)

1. Erpenbeck L, Schön MP. Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood 2010, 115:3427-3436. 10.1182/blood-2009-10-247296, 2867258, 20194899.
2. Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer 2011, 11:123-134. 10.1038/nrc3004, 21258396.
3. Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 2011, 20:576-590. 10.1016/j.ccr.2011.09.009, 3487108, 22094253.
4. Ho-Tin-Noé B, Goerge T, Cifuni SM, Duerschmied D, Wagner DD. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res 2008, 68:6851-6858. 10.1158/0008-5472.CAN-08-0718, 2547489, 18701510.
5. Ho-Tin-Noé B, Carbo C, Demers M, Cifuni SM, Goerge T, Wagner DD. Innate immune cells induce hemorrhage in tumors during thrombocytopenia. Am J Pathol 2009, 175:1699-1708. 10.2353/ajpath.2009.090460, 2751565, 19729481.
6. Feng W, Madajka M, Kerr BA, Mahabeleshwar GH, Whiteheart SW, Byzova TV. A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing. Blood 2011, 117:3893-3902. 10.1182/blood-2010-08-304808, 3083301, 21224474.
7. Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, Rupairmoole R, Armaiz-Pena GN, Pecot CV, Coward J, Deavers MT, Vasquez HG, Urbauer D, Landen CN, Hu W, Gershenson H, Matsuo K, Shahzad MM, King ER, Tekedereli I, Ozpolat B, Ahn EH, Bond V. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med 2012, 366:610-618. 10.1056/NEJMoa1110352, 3296780, 22335738.
8. Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2002, 2:38-47. 10.1038/nrc704, 11902584.
9. Pouysségur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006, 441:437-443. 10.1038/nature04871, 16724055.
10. Hwang SJ, Luo JC, Li CP, Chu CW, Wu JC, Lai CR, Chiang JH, Chau GY, Lui WY, Lee CC, Chang FY, Lee SD. Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma. World J Gastroenterol 2004, 10:2472-2477.
11. Carr BI, Guerra V. Thrombocytosis and hepatocellular carcinoma. Dig Dis Sci 2013, 58:1790-1796. 10.1007/s10620-012-2527-3, 23314854.
12. Cooke VG, LeBleu VS, Keskin D, Khan Z, O'Connell JT, Teng Y, Duncan MB, Xie L, Maeda G, Vong S, Sugimoto H, Rocha RM, Damascena A, Brentani RR, Kalluri R. Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell 2012, 21:66-81. 10.1016/j.ccr.2011.11.024, 22264789.
13. Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, Ma L, Chen J, McKnight GS, López JA, Yang L, Jin Y, Bray MS, Leal SM, Dong JF, Bray PF. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood 2011, 117:5189-5197. 10.1182/blood-2010-09-299719, 3109541, 21415270.
14. Ackah E, Yu J, Zoellner S, Iwakiri Y, Skurk C, Shibata R, Ouchi N, Easton RM, Galasso G, Birnbaum MJ, Walsh K, Sessa WC. Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest 2005, 115:2119-2127. 10.1172/JCI24726, 1180542, 16075056.
15. Liang Y, Besch-Williford C, Benakanakere I, Thorpe PE, Hyder SM. Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors. Breast Cancer Res Treat 2011, 125:407-420. 10.1007/s10549-010-0851-x, 2916972, 20349129.
16. Bendrik C, Robertson J, Gauldie J, Dabrosin C. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo. Cancer Res 2008, 68:3405-3412. 10.1158/0008-5472.CAN-08-0295, 18451168.
17. Dewever J, Frérart F, Bouzin C, Baudelet C, Ansiaux R, Sonveaux P, Gallez B, Dessy C, Feron O. Caveolin-1 is critical for the maturation of tumor blood vessels through the regulation of both endothelial tube formation and mural cell recruitment. Am J Pathol 2007, 171:1619-1628. 10.2353/ajpath.2007.060968, 2043522, 17916598.
18. Pirot N, Deleuze V, El-Hajj R, Dohet C, Sablitzky F, Couttet P, Mathieu D, Pinet V. LYL1 activity is required for the maturation of newly formed blood vessels in adulthood. Blood 2010, 115:5270-5279. 10.1182/blood-2010-03-275651, 20418284.
19. Carlson TR, Feng Y, Maisonpierre PC, Mrksich M, Morla AO. Direct cell adhesion to the angiopoietins mediated by integrins. J Biol Chem 2001, 276:26516-26525. 10.1074/jbc.M100282200, 11346644.
20. Shim WS, Ho IA, Wong PE. Angiopoietin: a TIE(d) balance in tumor angiogenesis. Mol Cancer Res 2007, 5:655-665. 10.1158/1541-7786.MCR-07-0072, 17634421.
21. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-676. 10.1038/nm0603-669, 12778165.
22. Sierko E, Wojtukiewicz MZ. Inhibition of platelet function: does it offer a chance of better cancer progression control?. Semin Thromb Hemost 2007, 33:712-721. 10.1055/s-2007-991540, 18000800.
23. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003, 200:429-447. 10.1002/path.1398, 12845611.
24. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, Selby PJ. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998, 77:956-964. 10.1038/bjc.1998.158, 2150108, 9528841.
25. Italiano JE, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S, Ryeom S, Folkman J, Klement GL. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008, 111:1227-1233. 2214735, 17962514.
26. Klement GL, Yip TT, Cassiola F, Kikuchi L, Cervi D, Podust V, Italiano JE, Wheatley E, Abou-Slaybi A, Bender E, Almog N, Kieran MW, Folkman J. Platelets actively sequester angiogenesis regulators. Blood 2009, 113:2835-2842. 10.1182/blood-2008-06-159541, 2661866, 19036702.
27. Grazia Lampugnani M, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F, Orsenigo F, Cattelino A, Kemler R, Daniel TO, Dejana E. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol 2003, 161:793-804. 10.1083/jcb.200209019, 2199373, 12771128.
28. Strilić B, Kucera T, Eglinger J, Hughes MR, McNagny KM, Tsukita S, Dejana E, Ferrara N, Lammert E. The molecular basis of vascular lumen formation in the developing mouse aorta. Dev Cell 2009, 17:505-515. 10.1016/j.devcel.2009.08.011, 19853564.
29. Labelle M, Schnittler HJ, Aust DE, Friedrich K, Baretton G, Vestweber D, Breier G. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling. Cancer Res 2008, 68:1388-1397. 10.1158/0008-5472.CAN-07-2706, 18316602.
30. Huang Y, Song N, Ding Y, Yuan S, Li X, Cai H, Shi H, Luo Y. Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis. Cancer Res 2009, 69:7529-7537. 10.1158/0008-5472.CAN-08-4382, 19773447.
31. Coupland LA, Chong BH, Parish CR. Platelets and p-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells. Cancer Res 2012, 72:4662-4671. 10.1158/0008-5472.CAN-11-4010, 22836751.